Hillsdale Investment Management Inc. Grows Stock Holdings in Maximus, Inc. (NYSE:MMS)

Hillsdale Investment Management Inc. grew its holdings in Maximus, Inc. (NYSE:MMS) by 0.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 52,400 shares of the health services provider’s stock after purchasing an additional 230 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Maximus were worth $3,912,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. UMB Bank n.a. increased its holdings in Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 158 shares in the last quarter. Eastern Bank purchased a new stake in shares of Maximus during the 4th quarter valued at about $29,000. V Square Quantitative Management LLC lifted its position in Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after acquiring an additional 180 shares in the last quarter. R Squared Ltd purchased a new position in Maximus in the 4th quarter worth approximately $54,000. Finally, IFP Advisors Inc grew its position in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after acquiring an additional 302 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Price Performance

MMS stock opened at $67.12 on Friday. The stock’s 50 day moving average is $71.07 and its two-hundred day moving average is $78.55. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The company has a market capitalization of $3.80 billion, a PE ratio of 14.43 and a beta of 0.71. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.79%. Maximus’s payout ratio is 25.81%.

Insider Buying and Selling

In related news, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

MMS has been the topic of a number of recent research reports. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a research report on Thursday, January 2nd. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.